Skip to main content
Fig. 3 | Virology Journal

Fig. 3

From: Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer

Fig. 3

Chemotherapy decreased STK31 expression in cervial cancer by upregulating its promoter/exon 1 methylation status. a MSP results showed that the chemotherapy treatment could increase methylation status of STK31 in CC cases. b qPCR showed that chemotherapy could decrease STK31 expression in CC samples. c qPCR showing that expression of STK31 was higher in samples before neoadjuvant chemotherapy than the specimens after chemotherapy

Back to article page

Virology Journal

ISSN: 1743-422X